Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Receivables (2017 - 2025)

Historic Receivables for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Dr Reddys Laboratories' Receivables changed N/A to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year change of. This contributed to the annual value of $1.1 billion for FY2025, which is 984.79% up from last year.
  • Dr Reddys Laboratories' Receivables amounted to $1.2 billion in Q4 2025.
  • Dr Reddys Laboratories' 5-year Receivables high stood at $1.2 billion for Q4 2025, and its period low was -$256.8 million during Q3 2021.
  • In the last 5 years, Dr Reddys Laboratories' Receivables had a median value of $858.1 million in 2021 and averaged $596.9 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Receivables tumbled by 128082.65% in 2021 and then surged by 234364.97% in 2025.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Receivables stood at $834.3 million in 2021, then rose by 9.57% to $914.1 million in 2022, then crashed by 96.44% to $32.5 million in 2023, then crashed by 253.5% to -$49.9 million in 2024, then skyrocketed by 2421.03% to $1.2 billion in 2025.
  • Its Receivables stands at $1.2 billion for Q4 2025, versus $1.1 billion for Q3 2025 and -$56.2 million for Q2 2025.